Stay updated on Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T20:22:55.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:21:07.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of versions of the study record for the clinical trial involving Quizartinib in patients with newly diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML). This change reflects the addition of a new version of the study record, which may include updated information or results.
    Difference
    0.3%
    Check dated 2024-05-22T20:56:54.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:27:49.000Z thumbnail image

Stay in the know with updates to Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib vs Chemo in FLT3-ITD (+) AML Clinical Trial page.